These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36017142)

  • 41. Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer.
    Ono M; Tsuda H; Shimizu C; Yamamoto S; Shibata T; Yamamoto H; Hirata T; Yonemori K; Ando M; Tamura K; Katsumata N; Kinoshita T; Takiguchi Y; Tanzawa H; Fujiwara Y
    Breast Cancer Res Treat; 2012 Apr; 132(3):793-805. PubMed ID: 21562709
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy.
    Darb-Esfahani S; Loibl S; Müller BM; Roller M; Denkert C; Komor M; Schlüns K; Blohmer JU; Budczies J; Gerber B; Noske A; du Bois A; Weichert W; Jackisch C; Dietel M; Richter K; Kaufmann M; von Minckwitz G
    Breast Cancer Res; 2009; 11(5):R69. PubMed ID: 19758440
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Triple-negative breast cancer: analysis of patients diagnosed and/or treated at the Masaryk Memorial Cancer Institute between 2004 and 2009].
    Svoboda M; Navrátil J; Fabian P; Palácová M; Gombošová J; Slámová L; Princ D; Syptáková B; Kudláček A; Bílek O; Pospíšil P; Kazda T; Grell P; Poprach A; Selingerová I; Nenutil R; Juráček J; Héžová R; Slabý O; Vyzula R
    Klin Onkol; 2012; 25(3):188-98. PubMed ID: 22724568
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinicopathological factors associated with novel prognostic markers for patients with triple negative breast cancer.
    Badowska-Kozakiewicz AM; Budzik MP; Liszcz A; Sobieraj MT; Czerw AI; Sobol M; Patera J; Deptała A
    Arch Med Sci; 2019 Oct; 15(6):1433-1442. PubMed ID: 31749871
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nottingham Prognostic Index in triple-negative breast cancer: a reliable prognostic tool?
    Albergaria A; Ricardo S; Milanezi F; Carneiro V; Amendoeira I; Vieira D; Cameselle-Teijeiro J; Schmitt F
    BMC Cancer; 2011 Jul; 11():299. PubMed ID: 21762477
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunohistochemical expression of cyclin D1 in invasive breast carcinoma and its correlation with clinicopathological parameters.
    Lengare PV; Sinai Khandeparkar SG; Joshi AR; Gogate BP; Solanke SG; Gore SH
    Indian J Pathol Microbiol; 2020; 63(3):376-381. PubMed ID: 32769325
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases.
    Anders CK; Deal AM; Miller CR; Khorram C; Meng H; Burrows E; Livasy C; Fritchie K; Ewend MG; Perou CM; Carey LA
    Cancer; 2011 Apr; 117(8):1602-11. PubMed ID: 21472708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer.
    Zhang M; Chen H; Wang M; Bai F; Wu K
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043519
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Subtype classification for prediction of prognosis of breast cancer from a biomarker panel: correlations and indications.
    Chen C; Yuan JP; Wei W; Tu Y; Yao F; Yang XQ; Sun JZ; Sun SR; Li Y
    Int J Nanomedicine; 2014; 9():1039-48. PubMed ID: 24591826
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic significance of proline, glutamic acid, leucine rich protein 1 (PELP1) in triple-negative breast cancer: a retrospective study on 129 cases.
    Zhang Y; Dai J; McNamara KM; Bai B; Shi M; Chan MS; Liu M; Sasano H; Wang X; Li X; Liu L; Ma Y; Cao S; Xing Y; Zhao B; Song Y; Wang L
    BMC Cancer; 2015 Oct; 15():699. PubMed ID: 26472563
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of SIRT1 is associated with lymph node metastasis and poor prognosis in both operable triple-negative and non-triple-negative breast cancer.
    Wu M; Wei W; Xiao X; Guo J; Xie X; Li L; Kong Y; Lv N; Jia W; Zhang Y; Xie X
    Med Oncol; 2012 Dec; 29(5):3240-9. PubMed ID: 22661383
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Triple-negative breast cancer is associated with EGFR, CK5/6 and c-KIT expression in Malaysian women.
    Kanapathy Pillai SK; Tay A; Nair S; Leong CO
    BMC Clin Pathol; 2012 Sep; 12():18. PubMed ID: 23009686
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinicopathological, therapeutic and prognostic features of the triple-negative tumors in moroccan breast cancer patients (experience of Hassan II university hospital in Fez).
    Akasbi Y; Bennis S; Abbass F; Znati K; Joutei KA; Amarti A; Mesbahi OE
    BMC Res Notes; 2011 Nov; 4():500. PubMed ID: 22088140
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Triple-negative breast cancer and basal-like subtype : Pathology and targeted therapy.
    Bando Y; Kobayashi T; Miyakami Y; Sumida S; Kakimoto T; Saijo Y; Uehara H
    J Med Invest; 2021; 68(3.4):213-219. PubMed ID: 34759133
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The expression of programmed death-ligand 1 in patients with invasive breast cancer.
    Meng Y; Wu H; Yao Y; Li R
    Gland Surg; 2020 Dec; 9(6):2106-2115. PubMed ID: 33447561
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinicopathological, Treatment and Event-Free Survival Characteristics in a Moroccan Population of Triple-Negative Breast Cancer.
    Mouh FZ; Slaoui M; Razine R; El Mzibri M; Amrani M
    Breast Cancer (Auckl); 2020; 14():1178223420906428. PubMed ID: 32425539
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer.
    Adamo B; Ricciardi GRR; Ieni A; Franchina T; Fazzari C; Sanò MV; Angelico G; Michele C; Tuccari G; Adamo V
    Oncotarget; 2017 Sep; 8(44):76974-76986. PubMed ID: 29100362
    [TBL] [Abstract][Full Text] [Related]  

  • 58. USP2 promotes cell migration and invasion in triple negative breast cancer cell lines.
    Qu Q; Mao Y; Xiao G; Fei X; Wang J; Zhang Y; Liu J; Cheng G; Chen X; Wang J; Shen K
    Tumour Biol; 2015 Jul; 36(7):5415-23. PubMed ID: 25687182
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Triple-Negative Metaplastic Breast Carcinoma: Association of Epidermal Growth Factor Receptor Expression With Prognostic Parameters and Clinical Outcome.
    Munawar S; Haider R; Ali SM; Yaqeen SR; Islam S; Asghar IA; Afzal A; Zia S; Irfan M; Hashmi AA
    Cureus; 2021 May; 13(5):e15006. PubMed ID: 34150374
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of triple-negative breast cancer phenotype on prognosis in patients with stage I breast cancer.
    Kim JE; Ahn HJ; Ahn JH; Yoon DH; Kim SB; Jung KH; Gong GY; Kim MJ; Son BH; Ahn SH
    J Breast Cancer; 2012 Jun; 15(2):197-202. PubMed ID: 22807937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.